Low-Avidity CD4+ T Cell Responses to SARS-CoV-2 in Unexposed Individuals and Humans with Severe COVID-19

未接触过SARS-CoV-2病毒的个体和重症COVID-19患者体内CD4+ T细胞对SARS-CoV-2的低亲和力反应

阅读:11
作者:Petra Bacher ,Elisa Rosati ,Daniela Esser ,Gabriela Rios Martini ,Carina Saggau ,Esther Schiminsky ,Justina Dargvainiene ,Ina Schröder ,Imke Wieters ,Yascha Khodamoradi ,Fabian Eberhardt ,Maria J G T Vehreschild ,Holger Neb ,Michael Sonntagbauer ,Claudio Conrad ,Florian Tran ,Philip Rosenstiel ,Robert Markewitz ,Klaus-Peter Wandinger ,Max Augustin ,Jan Rybniker ,Matthias Kochanek ,Frank Leypoldt ,Oliver A Cornely ,Philipp Koehler ,Andre Franke ,Alexander Scheffold

Abstract

CD4+ T cells reactive against SARS-CoV-2 can be found in unexposed individuals, and these are suggested to arise in response to common cold coronavirus (CCCoV) infection. Here, we utilized SARS-CoV-2-reactive CD4+ T cell enrichment to examine the antigen avidity and clonality of these cells, as well as the relative contribution of CCCoV cross-reactivity. SARS-CoV-2-reactive CD4+ memory T cells were present in virtually all unexposed individuals examined, displaying low functional avidity and multiple, highly variable cross-reactivities that were not restricted to CCCoVs. SARS-CoV-2-reactive CD4+ T cells from COVID-19 patients lacked cross-reactivity to CCCoVs, irrespective of strong memory T cell responses against CCCoV in all donors analyzed. In severe but not mild COVID-19, SARS-CoV-2-specific T cells displayed low functional avidity and clonality, despite increased frequencies. Our findings identify low-avidity CD4+ T cell responses as a hallmark of severe COVID-19 and argue against a protective role for CCCoV-reactive T cells in SARS-CoV-2 infection.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。